Before the market open on Thursday, the pediatric nutrition company reported earnings of 78 cents per share, surpassing analysts' forecasts for earnings of 73 cents per share.
Mead Johnson reported revenue of $967 million, which topped analysts' estimates for revenue of $966.05 million.
The company is expecting 2016 earnings to be between $3.48 per share and $3.60 per share.
"Our two biggest businesses in China and the United Statesboth posted sales above the levels experienced in the third quarter," CEO Kasper Jakobsen said in a statement. "I am also pleased that our Fuel for Growth initiative and our focus on operating expenses allowed us to deliver earnings per share above expectations within the fourth quarter."
So far today, 3.85 million shares of Mead Johnson have traded, versus its 30-day average of 2.4 million shares.
Separately, TheStreet Ratings currently has a Buy rating on the stock with a letter grade of B-.
The company's strengths can be seen in multiple areas, such as its notable return on equity and expanding profit margins.
Recently, TheStreet Ratings objectively rated this stock according to its "risk-adjusted" total return prospect over a 12-month investment horizon. Not based on the news in any given day, the rating may differ from Jim Cramer's view or that of this articles's author.
You can view the full analysis from the report here: MJN